Recent molecular reviews have reinforced these observations, highlighting recurrent mutations in TP53, KRAS, and other pathways as hallmarks of HPV-independent cervical adenocarcinomas [10,24,25]. This evidence concerns the gene TP53 and cervical adenocarcinoma.